• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Transmembrane protein 205 (TMEM205), Truncated

ACP08599

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP08599 Target NameTMEM205
Target SynonymsTMEM205; UNQ501/PRO1018; Transmembrane protein 205FormLyophilized powder
Expression SystemCustom Production. Please inquire and provide the desire expression system.Protein LengthPartial
Purity>85% (SDS-PAGE)Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ6UW68
Background Information
  • Uniprot Id

    Q6UW68

  • Target Species

    Human

  • Target Name

    TMEM205

  • Target Full Name

    Transmembrane protein 205

  • Target Function

    In cancer cells, plays a role in resistance to the chemotherapeutic agent cisplatin.

  • Target Subcellular Location

    Membrane; Multi-pass membrane protein. Note=Located on cell surface microvilli. In cancer cells, transition in subcellular location from cell surface to intracellular regions correlates the progression of cisplatin resistance.

  • Target Protein Families

    TMEM205 family

  • Target Tissue Specificity

    Widely expressed with highest levels in pancreas, followed by adrenal gland, thyroid, liver, mammary gland, prostate, kidney, and retina; lowest levels in skeletal muscle. Overexpressed in cisplatin-resistant cancer cells (at protein level).

  • Target Synonyms

    TMEM205; UNQ501/PRO1018; Transmembrane protein 205

Inquire Recombinant Human Transmembrane protein 205 (TMEM205), Truncated Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification